Cleared Traditional

K771525 - 125 I DIGOXIN RIA KIT

K771525 is an FDA 510(k) clearance for 125 I DIGOXIN RIA KIT, manufactured by Diagnostic Products Corp.. The device is a Class 2 Toxicology device with product code DPB cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K771525 · Diagnostic Products Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1977
Decision
67d
Days
Class 2
Risk

K771525 is an FDA 510(k) clearance for the 125 I DIGOXIN RIA KIT. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Charcoal Sep. (product code DPB), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Mchenry, US). The FDA issued a Cleared decision on October 14, 1977 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Products Corp. devices

FDA 510(k) Submission Details - K771525

510(k) Number K771525 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 1977
Decision Date October 14, 1977
Days to Decision 67 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 87d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPB Device Classification - Class 2, Special Controls

Product Code DPB Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Charcoal Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DPB Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Charcoal Sep.

Devices cleared under the same product code (DPB) and FDA review panel - the closest regulatory comparables to K771525.
DIGOXIN KIT
K823014 · Pcl-Ria, Inc. · Nov 1982
DIGOXIN RADIOIMMUNOASSAY
K820274 · American Diagnostic Corp. · Feb 1982
RIA TEST KIT, CENTRIA DIGOXIN
K790540 · Ventrex Laboratories, Inc. · Apr 1979
DIGI-TAB-RIA DIGOXIN RADIOMMUNOASSAY
K760883 · Nuclear Medical Laboratories, Inc. · Nov 1976